These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 19106598

  • 1. [Efficacy and safety of modified FOLFOX6 regimen in aged patients with nonresectable colorectal cancer].
    Ishiguro T, Ishibashi K, Okada N, Kuwabara K, Miyazaki T, Yokoyama M, Matsuki M, Sano M, Inoue N, Ishida H.
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2286-8. PubMed ID: 19106598
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H, Tsuboi K, Honda I, Kato N, Okochi O, Kobayashi D, Hattori M.
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
    Matsumoto S, Nishimura T, Kanai M, Mori Y, Nagayama S, Kawamura J, Nomura A, Miyamoto S, Kitano T, Ishiguro H, Yanagihara K, Teramukai S, Sakai Y, Chiba T, Fukushima M.
    Chemotherapy; 2008 May; 54(5):395-403. PubMed ID: 18781065
    [Abstract] [Full Text] [Related]

  • 4. [Safety and efficacy analysis of FOLFOX4 regimen in elderly compared to younger colorectal cancer patients].
    Kuboki Y, Ichimura T, Ogura M, Matsuda M, Suenaga M, Shinozaki E, Matsuzaka S, Chin K, Mizunuma N, Hatake K.
    Gan To Kagaku Ryoho; 2008 May; 35(5):781-5. PubMed ID: 18487913
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients].
    Young Kim W, Maeda K, Noda E, Fukunaga S, Inoue T, Kaizaki R, Shinto O, Wada K, Nakano T, Hirakawa K.
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1833-6. PubMed ID: 18030018
    [Abstract] [Full Text] [Related]

  • 6. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
    Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M, Barcelo R, Cervantes A, André T, Colin P, Louvet C, de Gramont A.
    Cancer; 2007 Dec 15; 110(12):2666-71. PubMed ID: 17963264
    [Abstract] [Full Text] [Related]

  • 7. [The prognosis of patients with an allergic reaction in the treatment of mFOLFOX6 therapy].
    Okada N, Ishibashi K, Kuwabara K, Ishiguro T, Hatano S, Hokama N, Tajima Y, Ishii M, Kubota S, Chika N, Miyazaki T, Ishida H.
    Gan To Kagaku Ryoho; 2009 Nov 15; 36(12):1985-7. PubMed ID: 20037299
    [Abstract] [Full Text] [Related]

  • 8. [Effect of withdrawal of 5-fluorouracil bolus administration on recovery from neutropenia in colorectal cancer patients treated with mFOLFOX6 chemotherapy-comparison with total dosage reduction].
    Ueda H, Demizu M, Oosawa M, Chihara S, Nakanishi Y, Maeda C, Yano K, Kimura F, Iwakawa S.
    Gan To Kagaku Ryoho; 2009 May 15; 36(5):789-93. PubMed ID: 19461179
    [Abstract] [Full Text] [Related]

  • 9. Modified FOLFOX-4 as first-line and salvage treatment in advanced gastric cancer.
    Baek YH, Choi SR, Jang JS, Roh MH, Lee JH, Won JJ, Lee CM.
    Hepatogastroenterology; 2011 May 15; 58(105):251-6. PubMed ID: 21510324
    [Abstract] [Full Text] [Related]

  • 10. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H, Ozaki T, Shiina M.
    Cardiovasc Intervent Radiol; 2009 Jul 15; 32(4):679-86. PubMed ID: 19296157
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatic metastatectomy of colorectal cancer following mFOLFOX6 treatment--analysis of 7 cases].
    Okada N, Ishibashi K, Yokoyama M, Kuwabara K, Hatano S, Ishii M, Kubota S, Chika N, Tamaru J, Miyazaki T, Ishida H.
    Gan To Kagaku Ryoho; 2009 Nov 15; 36(12):2028-31. PubMed ID: 20037313
    [Abstract] [Full Text] [Related]

  • 13. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
    Kanemitsu Y, Kato T, Shimizu Y, Inaba Y, Shimada Y, Nakamura K, Sato A, Moriya Y, Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group.
    Jpn J Clin Oncol; 2009 Jun 15; 39(6):406-9. PubMed ID: 19389795
    [Abstract] [Full Text] [Related]

  • 14. [Modified FOLFOX6(mFOLFOX6)in metastatic colorectal carcinoma patients with poor performance status].
    Nishi T, Hamamoto Y, Uemoto J, Onodera K, Warita E, Yamanaka Y.
    Gan To Kagaku Ryoho; 2012 Dec 15; 39(13):2557-60. PubMed ID: 23235179
    [Abstract] [Full Text] [Related]

  • 15. [Adjuvant chemotherapy comprising modified FOLFOX6 after curative resection of synchronous or metachronous metastasis from colorectal cancer].
    Hatano S, Ishibashi K, Amano K, Ishiguro T, Kuwabara K, Sobajima J, Ohsawa T, Okada N, Kumagai Y, Kumamoto K, Baba H, Tsuji Y, Haga N, Ishida H.
    Gan To Kagaku Ryoho; 2012 Nov 15; 39(12):2192-4. PubMed ID: 23268020
    [Abstract] [Full Text] [Related]

  • 16. [Chemotherapy with bevacizumab (BV)+modified FOLFOX6 for unresectable colorectal cancer].
    Matsumoto R, Kuroda T, Yamada H, Hasegawa K, Mamiya Y, Kon A.
    Gan To Kagaku Ryoho; 2009 Nov 15; 36(12):2207-9. PubMed ID: 20037372
    [Abstract] [Full Text] [Related]

  • 17. [Prediction of the efficacy of modified FOLFOX6 therapy according to the mRNA levels of thymidylate synthase (TS), excision repair cross-complementing-1 and -2( ERCC-1 and ERCC-2) and methylenetetrahydrofolate dehydrogenase( MTHFD) in the primary lesion of colorectal cancer].
    Ishibashi K, Okada N, Tajima Y, Ishiguro T, Kuwabara K, Ohsawa T, Kumamoto K, Tsuji Y, Haga N, Iwama T, Ishida H, Onouchi T, Yakabi K.
    Gan To Kagaku Ryoho; 2011 Nov 15; 38(12):2220-3. PubMed ID: 22202336
    [Abstract] [Full Text] [Related]

  • 18. Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience.
    Shimizu T, Satoh T, Tamura K, Ozaki T, Okamoto I, Fukuoka M, Nakagawa K.
    Int J Clin Oncol; 2007 Jun 15; 12(3):218-23. PubMed ID: 17566846
    [Abstract] [Full Text] [Related]

  • 19. [Modified FOLFOX6 in a patient on hemodialysis with metastatic colorectal cancer].
    Matoba S, Sawada T, Toda S, Moriyama J, Yokoyama T, Ehara K, Mine S, Ueno M, Kinoshita Y, Matsuda M, Tsutsumi K, Hashimoto M, Udagawa H, Watanabe G, Katori H, Hayashi M, Igarashi M, Ito T, Hasebe S, Sato M.
    Gan To Kagaku Ryoho; 2008 Apr 15; 35(4):673-5. PubMed ID: 18408443
    [Abstract] [Full Text] [Related]

  • 20. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage II colorectal cancer.
    Ito I, Mukai M, Ninomiya H, Kishima K, Tsuchiya K, Tajima T, Oida Y, Nakamura M, Makuuchi H.
    Oncol Rep; 2008 Nov 15; 20(5):1189-94. PubMed ID: 18949420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.